{"id":7564,"date":"2015-11-23T00:02:09","date_gmt":"2015-11-23T00:02:09","guid":{"rendered":"\/?p=7564"},"modified":"2015-11-23T00:15:01","modified_gmt":"2015-11-23T00:15:01","slug":"sunshine-biopharma-inc-otcmktssbfm-regains-ground-picks-up-volume","status":"publish","type":"post","link":"\/articles\/sunshine-biopharma-inc-otcmktssbfm-regains-ground-picks-up-volume\/","title":{"rendered":"Sunshine Biopharma, Inc. (OTCMKTS:SBFM) Regains Ground, Picks Up Volume"},"content":{"rendered":"\n<p><img decoding=\"async\" style=\"float: right;\" src=\"\/\/s.hotstocked.com\/hotstocked.com\/repository\/articles\/92\/92068\/sbfm_chart.png\" border=\"0\" width=\"450\" \/>After a disappointing few weeks that sent the share price of Sunshine Biopharma Inc (OTCMKTS:<a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=SBFM\">SBFM<\/a>) down to fresh 52-week lows at $0.0037 per share just last week, the stock is now pushing and shoving its way back up on considerable daily volume. Yesterday <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=SBFM\">SBFM<\/a> closed 26% up for a second day in a row and stopped at $0.0072 per share.<\/p>\n<p><a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=SBFM\">SBFM<\/a> is a biopharma focusing on cancer treatment. Its flagship product is called the Adva-27a and still has a long way in front of it. In early August 2015 The company announced the initial manufacturing sample of Adva-27a met all specifications, which cleared the way for the production of 2 kilograms to be used in clinical trials.<\/p>\n<p>The roadmap on <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=SBFM\">SBFM<\/a>&#8216;s website and the company&#8217;s latest report indicate this 2-kilo batch still has not been produced, as <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=SBFM\">SBFM<\/a> is &ldquo;conducting the next sequence of steps&rdquo;, that include the manufacture of the needed quantity, followed by investigational new drug enabling studies, filing for IND status and eventually Phase I clinical trials.<\/p>\n<p>The latest quarterly <a href=\"http:\/\/www.thehotpennystocks.com\/Stock-Quotes\/?stock=SBFM\">SBFM<\/a> furnished went live on Nov 4 and contained the following:<\/p>\n<ul style=\"list-style-type: disc;\">\n<li>$125 thousand in cash<\/li>\n<li>$136 thousand in total assets<\/li>\n<li>$469 thousand in total liabilities<\/li>\n<li>zero in quarterly revenues<\/li>\n<li>$202 thousand in quarterly net loss<\/li>\n<\/ul>\n<p>It&#8217;s somewhat disturbing to see a biopharma whose flagship product is still in early development spend only $8 thousand for research and development over the course of the first nine months of 2015 but this is exactly what the balance sheet states.<\/p>\n<p>The company had 137 million outstanding shares as of Nov 4, 2015. Out of those, 60 million saw the light of day between January and September 2015.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>After a disappointing few weeks that sent the share price of Sunshine Biopharma Inc (OTCMKTS:SBFM) down to fresh 52-week lows at $0.0037 per share just last week, the stock is now pushing and shoving&#46;&#46;&#46;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1939],"class_list":["post-7564","post","type-post","status-publish","format-standard","hentry","category-news","tag-sbfm"],"_links":{"self":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/7564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/comments?post=7564"}],"version-history":[{"count":0,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/posts\/7564\/revisions"}],"wp:attachment":[{"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/media?parent=7564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/categories?post=7564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/articles.thehotpennystocks.com\/articles\/wp-json\/wp\/v2\/tags?post=7564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}